TRIB Stock Catalyst: Trinity Biotech Receives WHO Approval for TrinScreen HIV Rapid Test Manufacturing

Jun 23, 2025 · 5:37pm ET

Approval granted for offshored and outsourced upstream manufacturing activities.

Max move

+84.1%

High of day $30.90

Sparker timei

5:37pm ET

TRIB · Jun 23, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Trinity Biotech plc announced on June 24, 2025, that it has received approval from the World Health Organization for the offshored and outsourced upstream manufacturing activities of its TrinScreen HIV rapid test.

The approval pertains specifically to the manufacturing processes conducted offshore and through outsourcing partners. No financial figures or share considerations were disclosed in the announcement.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time TRIB sparks.

Download Sniper App →

Catch the next TRIB-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →